FSD Cash Per Share from 2010 to 2024
| HUGE Stock | USD 0.48 0.01 2.13% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 0.08828702 | Current Value 0.0839 | Quarterly Volatility 0.74069036 |
Check FSD Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FSD main balance sheet or income statement drivers, such as Interest Expense of 289, Selling General Administrative of 11.4 K or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 278, Dividend Yield of 0.0 or PTB Ratio of 2.9. FSD financial statements analysis is a perfect complement when working with FSD Pharma Valuation or Volatility modules.
FSD | Cash Per Share |
Latest FSD Pharma's Cash Per Share Growth Pattern
Below is the plot of the Cash Per Share of FSD Pharma Class over the last few years. It is FSD Pharma's Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in FSD Pharma's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.83 X | 10 Years Trend |
|
Cash Per Share |
| Timeline |
FSD Cash Per Share Regression Statistics
| Arithmetic Mean | 0.51 | |
| Geometric Mean | 0.04 | |
| Coefficient Of Variation | 143.86 | |
| Mean Deviation | 0.54 | |
| Median | 0.09 | |
| Standard Deviation | 0.74 | |
| Sample Variance | 0.55 | |
| Range | 2.6266 | |
| R-Value | 0.33 | |
| Mean Square Error | 0.53 | |
| R-Squared | 0.11 | |
| Significance | 0.22 | |
| Slope | 0.06 | |
| Total Sum of Squares | 7.68 |
FSD Cash Per Share History
About FSD Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include FSD Pharma income statement, its balance sheet, and the statement of cash flows. FSD Pharma investors use historical funamental indicators, such as FSD Pharma's Cash Per Share, to determine how well the company is positioned to perform in the future. Although FSD Pharma investors may use each financial statement separately, they are all related. The changes in FSD Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on FSD Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on FSD Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in FSD Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Per Share | 0.09 | 0.08 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FSD Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FSD Pharma's short interest history, or implied volatility extrapolated from FSD Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of FSD Pharma Correlation against competitors. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.